MA41266A - Cataplasme - Google Patents

Cataplasme

Info

Publication number
MA41266A
MA41266A MA041266A MA41266A MA41266A MA 41266 A MA41266 A MA 41266A MA 041266 A MA041266 A MA 041266A MA 41266 A MA41266 A MA 41266A MA 41266 A MA41266 A MA 41266A
Authority
MA
Morocco
Prior art keywords
poultice
Prior art date
Application number
MA041266A
Other languages
English (en)
Inventor
Yasuhisa Kose
Keiichiro TSURUSHIMA
Takaaki Yoshinaga
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of MA41266A publication Critical patent/MA41266A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
MA041266A 2014-12-22 2015-12-13 Cataplasme MA41266A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014258878 2014-12-22

Publications (1)

Publication Number Publication Date
MA41266A true MA41266A (fr) 2017-10-31

Family

ID=56150252

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041266A MA41266A (fr) 2014-12-22 2015-12-13 Cataplasme

Country Status (10)

Country Link
US (1) US20170348247A1 (fr)
EP (1) EP3238725B1 (fr)
JP (3) JP6843622B2 (fr)
KR (1) KR102101544B1 (fr)
CN (1) CN107106577B (fr)
BR (1) BR112017013273A2 (fr)
HK (1) HK1245092A1 (fr)
MA (1) MA41266A (fr)
TW (1) TWI713481B (fr)
WO (1) WO2016104226A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3586833B1 (fr) * 2017-02-21 2021-07-07 Hisamitsu Pharmaceutical Co., Inc. Base de patch transdermique et patch transdermique l'utilisant
JP2020066592A (ja) * 2018-10-24 2020-04-30 帝國製薬株式会社 水性貼付剤
WO2021003315A1 (fr) * 2019-07-02 2021-01-07 Rowley Clifford T Timbre transdermique à perméabilité améliorée
WO2021192270A1 (fr) * 2020-03-27 2021-09-30 ニチバン株式会社 Timbre transdermique contenant de l'eau
CN115315262A (zh) * 2020-03-27 2022-11-08 日绊株式会社 贴剂
JP2024048993A (ja) * 2022-09-28 2024-04-09 ニチバン株式会社 貼付剤
CN117530917B (zh) * 2024-01-09 2024-04-05 北京中科利华医药研究院有限公司 柴胡栓剂
WO2025164529A1 (fr) * 2024-01-29 2025-08-07 久光製薬株式会社 Cataplasme
JP7712512B1 (ja) * 2024-01-29 2025-07-23 久光製薬株式会社 パップ剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5940853A (ja) * 1982-08-31 1984-03-06 第一製薬株式会社 乳化型パツプ剤
JPS59110616A (ja) * 1982-12-17 1984-06-26 Lion Corp 湿布剤
JPS6112614A (ja) * 1984-06-27 1986-01-21 Lion Corp 水性パップ剤
JPS61200918A (ja) * 1985-03-04 1986-09-05 Shiseido Co Ltd 外用消炎鎮痛剤
ATE222759T1 (de) * 1996-02-07 2002-09-15 Lead Chem Co Ltd Tranilast enthaltendes externum und verfahren zu dessen herstellung
JP3258576B2 (ja) 1996-10-09 2002-02-18 協和化学工業株式会社 パップ剤
JP2001302503A (ja) * 2000-04-17 2001-10-31 Oishi Koseido:Kk 貼付剤
WO2002100384A1 (fr) * 2001-06-12 2002-12-19 Hisamitsu Pharmaceutical Co., Inc. Timbre de type feuille
JP4073231B2 (ja) * 2002-03-28 2008-04-09 久光製薬株式会社 シ−ト状貼付剤
JP4318467B2 (ja) * 2003-02-24 2009-08-26 大協薬品工業株式会社 低皮膚刺激性硬膏剤及びその製造法
JP4596751B2 (ja) * 2003-06-11 2010-12-15 帝國製薬株式会社 消炎鎮痛貼付剤
JP2005126341A (ja) * 2003-10-22 2005-05-19 Lion Corp 外用消炎鎮痛貼付剤
WO2006090782A1 (fr) * 2005-02-23 2006-08-31 Saitama Daiichi Pharmaceutical Co., Ltd. Composition pour patch adhésif hydraté pour usage externe et patch adhésif comprenant ladite composition
JP2006321720A (ja) 2005-05-17 2006-11-30 Life Kea Giken Kk 貼付剤
JP5285279B2 (ja) * 2005-12-28 2013-09-11 久光製薬株式会社 経皮吸収型製剤
JP2008231010A (ja) 2007-03-20 2008-10-02 Shiseido Co Ltd 皮膚外用剤
US20100215721A1 (en) * 2007-05-17 2010-08-26 Kenichi Noguchi Poultice and process for producing the poultice
JP5319950B2 (ja) * 2008-04-08 2013-10-16 帝國製薬株式会社 塩酸ブテナフィン含有水性貼付剤
US8097275B2 (en) * 2008-04-23 2012-01-17 Kowa Company, Ltd. External skin patch
JP5999875B2 (ja) * 2011-03-30 2016-09-28 小林製薬株式会社 ゲル状医薬組成物
US20140302118A1 (en) * 2011-08-25 2014-10-09 Nipro Patch Co., Ltd. Hydrous adhesive skin patch

Also Published As

Publication number Publication date
HK1243331A1 (zh) 2018-07-13
EP3238725B1 (fr) 2022-02-02
JPWO2016104226A1 (ja) 2017-09-28
EP3238725A4 (fr) 2018-08-15
BR112017013273A2 (pt) 2018-01-09
WO2016104226A1 (fr) 2016-06-30
KR102101544B1 (ko) 2020-04-16
TWI713481B (zh) 2020-12-21
JP7201780B2 (ja) 2023-01-10
TW201628605A (zh) 2016-08-16
JP2020063303A (ja) 2020-04-23
JP6986581B2 (ja) 2021-12-22
JP2022016703A (ja) 2022-01-21
JP6843622B2 (ja) 2021-03-17
CN107106577B (zh) 2021-07-09
KR20170142159A (ko) 2017-12-27
CN107106577A (zh) 2017-08-29
EP3238725A1 (fr) 2017-11-01
HK1245092A1 (en) 2018-08-24
US20170348247A1 (en) 2017-12-07

Similar Documents

Publication Publication Date Title
NL301352I2 (nl) epcoritamab
NL301246I1 (nl) Glofitamab
NL301172I1 (nl) Lonapegsomatropine
DK3183051T3 (da) Væske-til-luftmembranenergivekslere
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3211743T3 (da) Ø-til-netværk-omskiftningsfremgangsmåde
FIC20265009I1 (fi) Brensocatib
DK3006072T3 (da) Karadgang
DK3222714T3 (da) Phytasemutanter
DK3119396T3 (da) Muscarinreceptoragonister
EP3230438C0 (fr) N-glycosylation
DK3110442T3 (da) Modificerede meningokok-fhbp-polypeptider
NO2024061I1 (no) Fruquintinib
EP4011484C0 (fr) Anhydrase carbonique de thermovibrio ammonificans
DK4242916T3 (da) Forstøver
DK3183340T3 (da) Termolabile exonukleaser
DE112015001664A5 (de) Betätigungsaktuator
MA41266A (fr) Cataplasme
EP4546794C0 (fr) Concept de raccordement audio
DK3154703T3 (da) Fuldkappe-snekkecentrifuge
DE112015005041A5 (de) Gargerätevorrichtung
DK3110439T3 (da) Pcsk9-vacciner
DE102014000623A8 (de) Halbhohlnietelement
DK3009858T3 (da) Skyradar
DE202014005655U8 (de) llluminationsvorrichtung